Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.330
+0.170 (4.09%)
At close: Mar 2, 2026, 4:00 PM EST
4.163
-0.167 (-3.85%)
Pre-market: Mar 3, 2026, 9:04 AM EST
Opus Genetics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Opus Genetics stock have an average target of 8.00, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 84.76% from the current stock price of 4.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Opus Genetics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $7 → $12 | Strong Buy | Maintains | $7 → $12 | +177.14% | Mar 2, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +61.66% | Jan 28, 2026 |
| BTIG | BTIG | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +61.66% | Jan 20, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +107.85% | Dec 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +61.66% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
13.62M
from 10.99M
Increased by 23.94%
Revenue Next Year
17.07M
from 13.62M
Increased by 25.28%
EPS This Year
-0.68
from -2.15
EPS Next Year
-0.45
from -0.68
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.0M | 31.5M | ||||
| Avg | 13.6M | 17.1M | ||||
| Low | 11.1M | 7.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 45.9% | 131.2% | ||||
| Avg | 23.9% | 25.3% | ||||
| Low | 0.7% | -42.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.56 | -0.30 | ||||
| Avg | -0.68 | -0.45 | ||||
| Low | -0.79 | -0.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.